But in the run-up to Trump's inauguration, the crypto rally has lost some heat. Bitcoin is down around 6% from its week-ago ...

Abivax Achieves Key Milestone in Phase 3 ABTECT Trial Enrollment Phase 3 ABTECT Trial evaluating obefazimod for moderately to severely active ulcerative colitis ("UC”) reaches 1,003 of 1,224 ...

Four Ward and Smith team members delivered concise, actionable insights on projected governmental and policy changes ...

Bitcoin falls to its lowest level since November, reaching as low as $92,500. The cryptocurrency's recent downturn suggests ...

NDAQ:ASML) ASML Holding N.V. Is Being Sued For Securities Law Violations And Impacted Investors Are Urged To Contact The Schall Law Firm ...

US Securities and Exchange Commission notes in its case against a consumer credit reporting corporation and investment fund ...

Ajay K. Puri, Nvidia’s executive vice president of worldwide field operations, sold shares on Monday and Tuesday.

Biologics License Application acceptance supported by results from the Phase 3 Vivacity-MG3 study Results demonstrate sustained disease control over 24 weeks in a broad ...

Share on Twitter Print Share by Email Share Back to top On December 20, 2024, the U.S. Securities and Exchange Commission (SEC) announced that ...

In the PET trial, RAP-219 achieved and exceeded target receptor occupancy, increasing support for the dosing regimen utilized in the ongoing Phase 2a trial in focal epilepsy; restricted ...

For a franchise long caught in a mire of mediocrity, the arrival of hope in the Washington Commanders has the team’s fanbase ...

Learn more about Zhengye Biotechnology Holding Limited's (ZYBT) stock grades for Value and determine whether this Pharmaceuticals stock meets your investment needs.